French pharmaceutical company Sanofi-Aventis SA states out that it’s net profit increased by 13.4 % in the 3rd quarter and thanks to tough demand in developing markets and achievements in the consumer health care sector.

Sanofi-Aventis Paris-based company stated out that the net profit of euro1.6 billion (US$2.2 billion) in the 3rd quarter, increased by euro1.4 billion per year previously.

The firm now wants its main earnings to increase between 0 and 2 % this current year at unchanging exchange rates, in comparison to a earlier prediction of a 0 to 4 % decline.